What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol

NACompletedINTERVENTIONAL
Enrollment

32,298

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 28, 2021

Study Completion Date

June 30, 2022

Conditions
Breast Cancer
Interventions
OTHER

BC-Predict

BC-Predict is an automated system for offering an assessment of breast cancer risk to women when they receive their NHS Breast Screening Programme invitation, and generating letters to feedback this risk to women and relevant healthcare professionals. Women at higher risk are offered chemoprevention drugs and additional mammography

OTHER

NHS Breast Screening Programme

usual care from NHS Breast Screening Programme, consisting of mammography every three years for most women.

Trial Locations (1)

M23 9LT

Manchester University NHS Foundation Trust, Manchester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

Breast Cancer Now

OTHER

collaborator

Prevent Breast Cancer

UNKNOWN

collaborator

Queen Mary University of London

OTHER

collaborator

University of Nottingham

OTHER

collaborator

Manchester University NHS Foundation Trust

OTHER_GOV

collaborator

East Lancashire Hospitals NHS Trust

OTHER

collaborator

East Cheshire NHS Trust

UNKNOWN

collaborator

NHS Breast Screening Programme

UNKNOWN

collaborator

The Christie NHS Foundation Trust

OTHER

lead

University of Manchester

OTHER

NCT04359420 - What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol | Biotech Hunter | Biotech Hunter